Cambridge Investment Research Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,930
| Closed | -$419K | – | 3287 |
|
|
2023
Q2 | $419K | Sell |
1,930
-70
| -4% | -$15.2K | ﹤0.01% | 2260 |
|
|
2023
Q1 | $363K | Sell |
2,000
-16
| -0.8% | -$2.9K | ﹤0.01% | 2320 |
|
|
2022
Q4 | $396K | Sell |
2,016
-40
| -2% | -$7.86K | ﹤0.01% | 2212 |
|
|
2022
Q3 | $462K | Sell |
2,056
-4,367
| -68% | -$981K | ﹤0.01% | 1998 |
|
|
2022
Q2 | $813K | Buy |
6,423
+4,251
| +196% | +$538K | ﹤0.01% | 1618 |
|
|
2022
Q1 | $275K | Buy |
2,172
+105
| +5% | +$13.3K | ﹤0.01% | 2612 |
|
|
2021
Q4 | $271K | Hold |
2,067
| – | – | ﹤0.01% | 2627 |
|
|
2021
Q3 | $253K | Buy |
2,067
+15
| +0.7% | +$1.84K | ﹤0.01% | 2616 |
|
|
2021
Q2 | $234K | Buy |
2,052
+64
| +3% | +$7.3K | ﹤0.01% | 2684 |
|
|
2021
Q1 | $239K | Sell |
1,988
-50
| -2% | -$6.01K | ﹤0.01% | 2465 |
|
|
2020
Q4 | $207K | Buy |
+2,038
| New | +$207K | ﹤0.01% | 2453 |
|